Bergmann S R, Herrero P, Markham J, Weinheimer C J, Walsh M N
Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.
J Am Coll Cardiol. 1989 Sep;14(3):639-52. doi: 10.1016/0735-1097(89)90105-8.
Noninvasive measurement of myocardial blood flow in absolute terms (i.e., milliliters per gram per min) has been difficult to accomplish despite the intrinsically quantitative power of positron emission tomography because of the nonphysiologic nature of tracers that have been employed conventionally as well as the limited spatial resolution of currently available instruments. It was previously demonstrated that myocardial blood flow in animals can be quantitated accurately with the diffusible tracer oxygen-15-labeled water (H2(15)O) when the arterial input function and myocardial radiotracer concentration were measured directly. To extend the approach for completely noninvasive measurement of blood flow, a parameter estimation procedure was developed whereby effects of limited tomographic spatial resolution and cardiac motion were compensated for within the operational flow model. In validation studies in 18 dogs, myocardial blood flow measured with positron emission tomography after intravenously administered H2(15)O correlated closely with flow measured with concomitantly administered radiolabeled microspheres over the range of 0.29 to 5.04 ml/g per min (r = 0.95). Although regional ischemia was clearly identifiable tomographically, absolute flow could not be determined accurately in ischemic regions in four dogs because of poor count statistics related to wall thinning. Subsequently, myocardial blood flow was measured in 11 normal human subjects. Flow was homogeneous throughout the myocardium, averaged 0.90 +/- 0.22 ml/g per min at rest and increased to 3.55 +/- 1.15 ml/g per min after intravenous administration of dipyridamole. Therefore, positron emission tomography with H2 15O and the approach developed permits noninvasive measurement of myocardial blood flow in absolute terms in humans and should facilitate objective assessment of interventions designed to enhance nutritive perfusion.
尽管正电子发射断层扫描具有内在的定量能力,但由于传统上使用的示踪剂的非生理性质以及现有仪器有限的空间分辨率,以绝对值(即每分钟每克毫升数)无创测量心肌血流量一直难以实现。先前的研究表明,当直接测量动脉输入函数和心肌放射性示踪剂浓度时,使用可扩散示踪剂氧-15标记水(H2(15)O)可以准确地定量动物心肌血流量。为了扩展完全无创测量血流量的方法,开发了一种参数估计程序,通过该程序在操作血流模型中补偿有限断层空间分辨率和心脏运动的影响。在对18只狗的验证研究中,静脉注射H2(15)O后用正电子发射断层扫描测量的心肌血流量与同时注射放射性标记微球测量的血流量在0.29至5.04毫升/克每分钟的范围内密切相关(r = 0.95)。尽管断层扫描能够清晰地识别局部缺血,但由于与心肌壁变薄相关的计数统计不佳,四只狗缺血区域的绝对血流量无法准确测定。随后,对11名正常人类受试者进行了心肌血流量测量。心肌血流量在整个心肌中均匀分布,静息时平均为0.90±0.22毫升/克每分钟,静脉注射双嘧达莫后增加到3.55±1.15毫升/克每分钟。因此,使用H2 15O的正电子发射断层扫描和所开发的方法可以无创地以绝对值测量人类心肌血流量,并且应该有助于客观评估旨在增强营养灌注的干预措施。